About us Contact Terms of Use Data Sources Publications FAQ
RASD2 logo

RASD2

GTP-binding protein Rhes

Expression

StudyTumor samplesMaxQ3Q2Q1MinNormal samplesMaxQ3Q2Q1MinLog2 (T vs N)
Adrenocortical (ACC) 77 2.06 1.44 1.18 1.00 0.38 126 2.03 1.37 1.10 0.92 -0.09 0.08
Bladder (BLCA) 406 2.61 1.24 1.00 0.80 -0.01 9 1.70 1.57 1.28 1.06 0.96 -0.28
Breast (BRCA) 1067 2.52 1.53 1.29 1.10 0.35 178 1.63 1.28 1.12 0.98 0.52 0.16
Cervical (CESC) 297 2.57 1.00 0.75 0.53 -0.15 10 1.33 1.22 1.08 0.91 0.79 -0.32
Cholangiocarcinoma (CHOL) 36 1.70 1.11 0.89 0.67 0.44 0
Colon (COAD) 443 2.39 1.36 1.15 0.95 0.01 166 2.39 1.85 1.63 1.48 -0.09 -0.48
B-cell lymphoma (DLBC) 42 1.10 0.80 0.63 0.44 -0.05 337 1.28 0.07 -0.56 -0.20 -0.01 1.19
Esophageal (ESCA) 142 2.01 1.38 1.17 0.97 0.46 271 2.26 0.93 0.79 0.66 -0.09 0.38
Glioblastoma (GBM) 160 1.76 1.33 1.18 1.02 0.63 214 2.20 1.37 1.28 1.19 -0.09 -0.10
Head and neck (HNSC) 432 2.36 1.33 1.03 0.74 -0.31 55 1.46 1.26 1.18 0.98 0.33 -0.15